CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting Oct 31, 2025 11:35AM
CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering Oct 13, 2025 07:30AM
CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth Sep 24, 2025 09:10AM
CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market Sep 8, 2025 08:35AM
CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC") Jul 16, 2025 09:15AM


Jun 18, 2025 09:00AM CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT
Apr 15, 2025 09:35AM CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS
Mar 12, 2025 08:30AM OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval